Arrowhead Pharmaceuticals
ARWR
#2176
Rank
A$12.78 B
Marketcap
A$92.50
Share price
-4.98%
Change (1 day)
167.53%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Cash on Hand

Cash on Hand as of June 2025 : A$1.35 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company has A$1.35 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Arrowhead Pharmaceuticals - Cash on Hand chart (from 1999 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30A$0.98 B56.81%
2023-09-30A$0.62 B7.3%
2022-09-30A$0.58 B15.06%
2021-09-30A$0.50 B15.53%
2020-09-30A$0.44 B14.92%
2019-09-30A$0.38 B261.59%
2018-09-30A$0.10 B26.69%
2017-09-30A$83.62 M-25.18%
2016-09-30A$0.11 B-20.66%
2015-09-30A$0.14 B-20.16%
2014-09-30A$0.17 B484.31%
2013-09-30A$30.19 M797.58%
2012-09-30A$3.36 M-59.75%
2011-09-30A$8.35 M17.72%
2010-09-30A$7.09 M205.2%
2009-09-30A$2.32 M-81.74%
2008-09-30A$12.74 M-52.76%
2007-09-30A$26.96 M-28.2%
2006-09-30A$37.56 M26.53%
2005-09-30A$29.68 M135.38%
2004-09-30A$12.61 M531.46%
2003-09-30A$1.99 M5771.88%
2002-09-30A$0.03 M6073.1%
2001-09-30A$0 M-84.63%
2000-09-30A$0 M1788.89%
1999-09-30A$0 M-88.94%
1998-09-30A$0 M6.83%
1997-09-30A$0 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Alnylam Pharmaceuticals
ALNY
A$4.10 B 202.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$1.01 B-24.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
A$76.48 M-94.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$27.94 B 1,961.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
A$6.78 B 400.24%๐Ÿ‡บ๐Ÿ‡ธ USA